VR Logo

Oxygenta Pharmaceutical: Announcement under Regulation 30 (LODR)-Change of Company Name


Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform to the shareholders of the Company that the Company has received approval from BSE Limited for change in name of the Company from existing S.S. Organics Ltd. to new Oxygenta Pharmaceutical Limited vide its letter dated 27th June 2022 (enclosed as under) with a Scrip ID for BOLT Plus System as OXYGENTAPH which will be with effective from 01st July 2022 in BSE Website.Requesting all the stakeholders of the Company to take note on the same.

Click here to view PDF